Navigation Links
Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
Date:4/13/2009

SUNNYVALE, Calif., April 13 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it has begun treating patients in a Phase 1 dose-escalation study to evaluate the safety and tolerability of PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, as a potential treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL). This is the first Btk selective inhibitor to be tested in humans, and is Pharmacyclics' fourth product in clinical development.

Bruton's tyrosine kinase is the gene that is disrupted in the human disease X-linked agammaglobulenemia (XLA). Patients with XLA are devoid of mature B-lymphocytes and immunoglobulins in the bloodstream, but are otherwise healthy. XLA thus provides strong clinical rationale for development of a novel therapeutic drug targeting Btk for safe inhibition of B-cell mediated diseases. In preclinical studies, PCI-32765 has the remarkable ability to selectively inhibit human B-cell activation without effecting T cells. Strong preclinical validation of Btk as a target in lymphoma was generated using PCI-32765 in a mouse model of B-cell receptor-driven lymphoma and in spontaneous B-cell lymphoma in companion canines. These studies will be reported in presentations at the 2009 AACR annual meeting in Denver, Colorado (see below). Unlike anti-CD20 protein therapies, treatment with PCI-32765 in animal models is not myeloablative, which could result in prolonged and dangerous immunosuppression for the patient.

"This is a very selective compound for B-cells, and it could represent an important alternative to rituximab therapy for the treatment of B-cell NHL. Other obvious applications include autoimmune disorders such as rheumatoid arthritis and lupus, and Pharmacyclics also has strong prec
'/>"/>

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
2. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
3. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
6. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
7. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
8. Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
9. Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes
10. Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
11. Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 For its innovative modular ... , Art,s-Way Scientific has earned a Modular Building ... competition in over 30 categories, MBI,s contest is the ... which include building manufacturers, dealers, and product and service ... example the capability of our team," said Dan ...
(Date:7/31/2014)... , July 31, 2014 genae, a global ... announced today the incorporation of genae UK in London ... has one of the largest medical device markets in the world. ... is projected to increase by a CAGR of 6.0% until 2017. ... to 9.5% of GDP. Despite recessionary pressures, market growth rates over ...
(Date:7/31/2014)... , July 31, 2014 TB Alliance, ... developing better, faster and affordable treatments, announced the ... Vice President, External Affairs. Mr. Brock comes to ... of Major Donor Relations for WWF International (formerly ... role, Mr. Brock will guide the TB Alliance,s ...
Breaking Medicine Technology:Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... BRAUNFELS, Texas , May 21 The SCOOTER Store is ... Science Center San Antonio, believing that teaching ethics and humanitarian values to ... elderly. , , , ... of The SCOOTER Store is to create an opportunity for every American ...
... BOSTON , May 21  Solos Endoscopy, Inc. (Pink ... to its board of directors as Chief Financial Officer. Mr. Schiemann ... as expertise in taxation, auditing and public securities work. , ... Mr. Schiemann previously served as the Chief ...
Cached Medicine Technology:The SCOOTER Store Invests in Ethics Training for Future Doctors 2The SCOOTER Store Invests in Ethics Training for Future Doctors 3Solos Endoscopy, Inc. Appoints Experienced CFO To Financial Leadership Amidst Growth 2
(Date:7/31/2014)... Setting goals for a fitness program is very ... to weight loss. Fitness on the Go has been helping ... has worked with 6000 customers on an individual basis throughout ... to monitor why customers start exercising with a personal ... to their program, whether or not they have a goal ...
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular advancement splint ... snorers airway to quiet snoring. , Dawn M. of Utah ... her husband by allowing them to share the same bedroom again. ... about 15 years ago and I remember nights when it was ... had to head downstairs for any relief. As the years have ...
(Date:7/31/2014)... York (PRWEB) July 31, 2014 ... as Bernstein Liebhard LLP notes that Johnson & ... plans to voluntarily remove its power morcellators ( ... report from Bloomberg.com, the company said it decided ... associated with the devices remain uncertain.* , “In ...
(Date:7/31/2014)... London, UK (PRWEB) July 31, 2014 ... in the development and maintenance of products in the ... can be performed by using various products and equipment ... and spoilage of various materials and products. , ... and services is forecast to post a CAGR of ...
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July 31, 2014 (HealthDay ... has shown an increased risk of spreading undetected cancers in ... market. In a letter that was to be sent ... that its laparoscopic power morcellators be returned to the company, ... of new morcellators had been suspended in April after the ...
Breaking Medicine News(10 mins):Health News:Fitness on the Go's Rewards Program Helps Clients Reach Their Goals 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 2Health News:Uterine Morcellation Controversy Grows, as Bernstein Liebhard LLP Notes Johnson & Johnson Decision to Withdraw Power Morcellators from Market 3Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 2Health News:Infection Prevention and Control Market to Post about 7.5% CAGR through 2018, States Infiniti Research in Its Study Published at MarketPublishers.com 3Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 2Health News:J&J Pulls Hysterectomy Tool Tied to Cancer Risk From Market 3
... BOSTON, Dec. 14 When Kurth ... instructions for landing on the moon, he,was confident that technology ... there was one thing that science couldn,t solve.,His wife Susan ... her alive for awhile, she would die without a transplant. ...
... , MONDAY, Dec. 14 (HealthDay News) -- Here,s good news for ... of java: Coffee and tea consumption may decrease the risk of ... Australian study that also found the more coffee you drink, the ... with a 7 percent reduction in the risk of diabetes, the ...
... treatments for asthma, COPD, researchers say , MONDAY, Dec. ... variants that influence lung function, a finding that may ... The international team of researchers compared lung function with ... across the human genome in more than 20,000 people ...
... ... But Nets tipped off a promotion--Send a Net. Save a Life. See a Game. presented ... part of the NBA Cares Season of Giving and runs through January 31, 2010. ... New York, NY ...
... Hospital records show consistent rate of lacerations, accidental ingestion of ... A new study from Children,s Hospital Boston,s Division of ... are one more safety hazard parents must consider during the ... an average of five ornament-related injuries per year, more than ...
... to approve naming the women,s hospital -- located within the C.S. ... Jane Von Voigtlander , ANN ARBOR, Mich., Dec. 14 ... gift from the Ted and Jane Von Voigtlander Foundation, the largest ... will support the construction of a new women,s hospital. , The ...
Cached Medicine News:Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 2Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 3Health News:NBA Cares and United Nations Foundation Partner to Launch Send A Net. Save A Life. See A Game. Presented By HP 4Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5
... A disposable lever action ... angled head that is designed ... of your work from your ... Staplers are available in four ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
100L...
Medicine Products: